NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UNGet Free Report) had its target price hoisted by Royal Bank Of Canada from C$5.50 to C$6.00 in a research report issued on Wednesday,BayStreet.CA reports. The firm presently has a “sector perform” rating on the stock. Royal Bank Of Canada’s target price suggests a potential upside of 3.09% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the stock. Canadian Imperial Bank of Commerce lifted their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research report on Thursday, November 13th. Scotiabank lifted their price objective on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a report on Thursday, November 13th. BMO Capital Markets increased their target price on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a report on Thursday, November 13th. Finally, ATB Cormark Capital Markets lowered NorthWest Health Prop Real Est Inv Trust from an “outperform” rating to a “sector perform” rating and set a C$6.25 price target on the stock. in a research report on Friday, February 27th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of C$6.13.

Check Out Our Latest Report on NorthWest Health Prop Real Est Inv Trust

NorthWest Health Prop Real Est Inv Trust Stock Down 1.0%

NWH.UN opened at C$5.82 on Wednesday. The business’s fifty day simple moving average is C$5.64 and its 200 day simple moving average is C$5.31. NorthWest Health Prop Real Est Inv Trust has a 52 week low of C$4.44 and a 52 week high of C$6.07. The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. The stock has a market cap of C$1.45 billion, a PE ratio of 28.79, a P/E/G ratio of 0.74 and a beta of 1.78.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UNGet Free Report) last posted its quarterly earnings data on Tuesday, February 24th. The company reported C($0.16) earnings per share (EPS) for the quarter. The firm had revenue of C$102.27 million during the quarter. NorthWest Health Prop Real Est Inv Trust had a negative return on equity of 14.67% and a negative net margin of 75.29%. As a group, research analysts expect that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 earnings per share for the current fiscal year.

About NorthWest Health Prop Real Est Inv Trust

(Get Free Report)

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

Recommended Stories

Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.